Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 39 Records) |
Query Trace: Carcinoma and C2[original query] |
---|
The influence of HLA alleles and HBV subgenotyes on the outcomes of HBV infections in Northeast China. Virus research 2012 Jan 163 (1): 328-33. Li Xingku, Liu Wei, Wang Hongyan, Jin Xi, Fang Shaohong, Shi Yuguang, Liu Zhen, Zhang Shuyun, Yang Shuf |
Association of genetic polymorphisms of aldehyde dehydrogenase-2 and cytochrome P450 2E1-RsaI and alcohol consumption with oral squamous cell carcinoma. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 2012 Aug 34 (4): 390-5. Guo Li-ke, Zhang Chao-xian, Guo Xiao-fe |
KIR2DL2/S2 and HLA-C C1C1 genotype is associated with better response to treatment and prolonged survival of patients with non-small cell lung cancer in a Polish Caucasian population. Human immunology 2012 Jul . Wi?niewski A, Jankowska R, Passowicz-Muszy?ska E, Wi?niewska E, Majorczyk E, Nowak I, Frydecka I, Ku?nierczyk P |
CYP2E1 PstI/RsaI polymorphism and interaction with alcohol consumption in hepatocellular carcinoma susceptibility: evidence from 1,661 cases and 2,317 controls. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012 Aug 33 (4): 979-84. Liu Chibo, Wang Haibao, Pan Chunqin, Shen Jianmin, Liang Yo |
Nonequivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Jul 19 (13): 3474-84. George Joshy, Alsop Kathryn, Etemadmoghadam Dariush, Hondow Heather, Mikeska Thomas, Dobrovic Alexander, deFazio Anna, , Smyth Gordon K, Levine Douglas A, Mitchell Gillian, Bowtell David |
Genetic polymorphisms of CYP2E1 and DNA repair genes HOGG1 and XRCC1: association with hepatitis B related advanced liver disease and cancer. Gene 2013 May 519 (2): 231-7. Bose Sujoy, Tripathi Dinesh M, Sukriti , Sakhuja Puja, Kazim Syed N, Sarin Shiv |
A sequence variant in the phospholipase C epsilon C2 domain is associated with esophageal carcinoma and esophagitis. Molecular carcinogenesis 2013 Nov 52 Suppl 1 E80-6. Wang Li-Dong, Bi Xiuli, Song Xin, Pohl Nicole M, Cheng Yulan, Zhou Yixing, Shears Stephen, Ansong Emmanuel, Xing Mengtao, Wang Shaomeng, Xu Xiao-Chun, Huang Peng, Xu Liyan, Wang Liang, Fan Zongmin, Zhao Xueke, Dong Huali, Meltzer Stephen J, Ding Ivan, Yang Wanc |
Cytochrome P450 2E1 gene polymorphism and alcohol drinking on the risk of hepatocellular carcinoma: a meta-analysis. Molecular biology reports 2014 Nov 41 (11): 7645-50. Liu Wei, Tian Fang, Dai Liping, Chai Yuro |
Quantitative effect of natural killer-cell licensing on hepatocellular carcinoma recurrence after curative hepatectomy. Cancer immunology research 2014 Dec 2 (12): 1142-7. Tanimine Naoki, Tanaka Yuka, Kobayashi Tsuyoshi, Tashiro Hirotaka, Miki Daiki, Imamura Michio, Aikata Hiroshi, Tanaka Junko, Chayama Kazuaki, Ohdan Hide |
Association of killer cell immunoglobulin-like receptor gene 2DL1 and its HLA-C2 ligand with family history of cancer in oral squamous cell carcinoma. Immunogenetics 2014 Aug 66 (7-8): 439-48. Dutta Anupam, Saikia Nabajyoti, Phookan Jyotirmoy, Baruah Munindra Narayan, Baruah Shas |
CYP1A1 and CYP2E1 genotypes and risk of esophageal squamous cell carcinoma in a high-incidence region, Kashmir. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jun 35 (6): 5323-30. Bhat Gulzar Ahmad, Shah Idrees Ayoub, Makhdoomi Muzamil Ashraf, Iqbal Beenish, Rafiq Rumaisa, Nabi Sumaiya, Masood Akbar, Lone Mohd Maqbool, Dar Nazir Ahm |
Genetic variations in STAT4,C2,HLA-DRB1 and HLA-DQ associated with risk of hepatitis B virus-related liver cirrhosis. Scientific reports 2015 5 16278. Jiang De-Ke, Ma Xiao-Pin, Wu Xiaopan, Peng Lijun, Yin Jianhua, Dan Yunjie, Huang Hui-Xing, Ding Dong-Lin, Zhang Lu-Yao, Shi Zhuqing, Zhang Pengyin, Yu Hongjie, Sun Jielin, Lilly Zheng S, Deng Guohong, Xu Jianfeng, Liu Ying, Guo Jinsheng, Cao Guangwen, Yu Lo |
[Genetic polymorphism of cytochrome P450 2E1 and the risk of nasopharyngeal carcinoma]. Bulletin du cancer 2015 Nov . Ben Chaaben Arij, Abaza Hajer, Douik Hayet, Chaouch Leila, Ayari Fayza, Ouni Nesrine, Mamoghli Tasnim, Ben Guezella Dorra, Mejri Rachida, Harzallah Latifa, Guemira Fet |
Clinical utility of complex mutations in the core promoter and proximal precore regions of the hepatitis B virus genome. World journal of hepatology 2015 Jan 7 (1): 113-20. Park Young M |
Does CYP2E1 RsaI/PstI polymorphism confer head and neck carcinoma susceptibility?: A meta-analysis based on 43 studies. Medicine 2016 Oct 95 (43): e5156. Zhuo Xianlu, Song Jue, Liao Jian, Zhou Wei, Ye Huiping, Li Qi, Xiang Zhaolan, Zhang Xueyu |
Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells. Cancer research 2016 Jan . Vineretsky Karin A, Karagas Margaret R, Christensen Brock C, Kuriger-Laber Jacquelyn K, Perry Ann E, Storm Craig A, Nelson Heather |
Genetic association of complement component 2 variants with chronic hepatitis B in a Korean population. Liver international : official journal of the International Association for the Study of the Liver 2017 Dec . Namgoong Suhg, Shin Joong-Gon, Cheong Hyun Sub, Kim Lyoung Hyo, Kim Ji On, Seo Jung Yeon, Shin Hyoung Doo, Kim Yoon J |
Clinical implication and viral mutation in basal core promoter/pre-core of hepatitis B virus C/D recombinant. Hepatology international 2018 7 12 (5): 447-455. Li Hua, She Qilu, Liu Yu, Ding Yuehe, Shi Shenghua, Li Jijie, Wu Hongkai, Wang Zhanh |
KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients. Oncotarget 2018 Apr 9 (28): 19650-19661. Saito Hiromi, Umemura Takeji, Joshita Satoru, Yamazaki Tomoo, Fujimori Naoyuki, Kimura Takefumi, Komatsu Michiharu, Matsumoto Akihiro, Tanaka Eiji, Ota Mas |
Genetic variants of ALDH2-rs671 and CYP2E1-rs2031920 contributed to risk of hepatocellular carcinoma susceptibility in a Chinese population. Cancer management and research 2018 10 1037-1050. Ye Xinping, Wang Xiangkun, Shang Liming, Zhu Guangzhi, Su Hao, Han Chuangye, Qin Wei, Li Guanghui, Peng T |
Unraveling most abundant mutational signatures in head and neck cancer. International journal of cancer 2020 Sep . Plath Michaela, Gass Johanna, Hlevnjak Mario, Li Qiaoli, Feng Bohai, Hostench Xavier Pastor, Bieg Matthias, Schroeder Lea, Holzinger Dana, Zapatka Marc, Freier Kolja, Weichert Wilko, Hess Jochen, Zaoui Kar |
Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma. BioMed research international 2020 2020 3765937. Ning Gang, Huang Yan-Lin, Zhen Li-Min, Xu Wen-Xiong, Li Xue-Jun, Wu Li-Na, Liu Ying, Xie Chan, Peng Lia |
Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2020 1 29 (4): 832-837. Kim Seung Up, Seo Yeon Seok, Lee Han Ah, Kim Mi Na, Lee Eun Ju, Shin Hye Jung, Lee Yu Rim, Lee Hye Won, Park Jun Yong, Kim Do Young, Ahn Sang Hoon, Han Kwang-Hyub, Um Soon Ho, Tak Won Young, Kweon Young Oh, Kim Beom Kyung, Park Soo You |
Identification of the prognostic value of a 2-gene signature of the WNT gene family in UCEC using bioinformatics and real-world data. Cancer cell international 2021 Sep 21 (1): 516. Hu Yuexin, Zheng Mingjun, Zhang Dandan, Gou Rui, Liu Ouxuan, Wang Shuang, Lin B |
Characterization of Hypoxia-Related Molecular Subtypes in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy and Targeted Therapy via Multi-Omics Analysis. Frontiers in molecular biosciences 2021 7 8 684050. Zhong Weimin, Zhong Hongbin, Zhang Fengling, Huang Chaoqun, Lin Yao, Huang Ji |
Three Prognostic Biomarkers Correlate with Immune Checkpoint Blockade Response in Bladder Urothelial Carcinoma. International journal of genomics 2022 2022 3342666. Guo Ya, Zhang Yin Bin, Li Yi, Su Wang Hui, He Shan, Pan Shu Pei, Xu Kun, Kou Wei H |
Identification of tumour antigens and immune subtypes in the development of an anti-cancer vaccine for endometrial carcinoma. Scandinavian journal of immunology 2022 12 97 (3): e13250. Feng Jianyang, He Ho |
Comprehensive analysis of the clinical significance, immune infiltration, and biological role of MARCH ligases in HCC. Frontiers in immunology 2022 10 13 997265. Cao Jun, Tu Dao-Yuan, Zhou Jie, Jiang Guo-Qing, Jin Sheng-Jie, Su Bing-Bing, Tang Hao, Tang Yu-Hong, Wang Ao-Qing, Wang Qian, Liu Ren-Jie, Zhang Chi, Bai Dou-She |
Identification of secretory pathway-related genes based on Random Forest algorithm to predict the prognosis and immunotherapy response of hepatocellular carcinoma. The journal of gene medicine 2023 9 e3593. Zanzhi Wang, Pengwei Shi, Peng Huang, Chun Xu, Yaoquan He, Wenxiong L |
A Systematic Pan-Cancer Analysis of MEIS1 in Human Tumors as Prognostic Biomarker and Immunotherapy Target. Journal of clinical medicine 2023 2 12 (4): . Li Han, Tang Ying, Hua Lichun, Wang Zemin, Du Guoping, Wang Shuai, Lu Shifeng, Li W |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: